SCM
IDXX icon

Shelton Capital Management’s Idexx Laboratories IDXX Stock Holding History

Shelton Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.68M Sell
8,889
-433
-5% -$243K 0.09% 159
2026
Q1 		$5.24M Sell
9,322
-218
-2% -$140K 0.11% 140
2025
Q4 		$6.45M Buy
9,540
+128
+1% +$87.2K 0.13% 135
2025
Q3 		$6.01M Sell
9,412
-234
-2% -$142K 0.13% 142
2025
Q2 		$5.17M Sell
9,646
-546
-5% -$261K 0.12% 156
2025
Q1 		$4.28M Sell
10,192
-661
-6% -$287K 0.1% 167
2024
Q4 		$4.49M Hold
10,853
– – 0.11% 165
2024
Q3 		$5.48M Hold
10,853
– – 0.14% 142
2024
Q2 		$5.29M Hold
10,853
– – 0.14% 143
2024
Q1 		$5.86M Buy
10,853
+156
+1% +$85.3K 0.17% 136
2023
Q4 		$5.94M Buy
10,697
+864
+9% +$406K 0.19% 132
2023
Q3 		$4.3M Buy
9,833
+2,000
+26% +$997K 0.16% 159
2023
Q2 		$3.93M Buy
7,833
+289
+4% +$138K 0.14% 154
2023
Q1 		$3.77M Buy
7,544
+1,012
+15% +$484K 0.16% 143
2022
Q4 		$2.66M Sell
6,532
-1,381
-17% -$536K 0.28% 124
2022
Q3 		$2.58M Hold
7,913
– – 0.12% 174
2022
Q2 		$2.77M Hold
7,913
– – 0.12% 174
2022
Q1 		$4.33M Buy
7,913
+325
+4% +$171K 0.16% 145
2021
Q4 		$5M Sell
7,588
-18
-0.2% -$11.3K 0.18% 126
2021
Q3 		$4.73M Buy
7,606
+127
+2% +$85.3K 0.18% 121
2021
Q2 		$4.72M Hold
7,479
– – 0.18% 125
2021
Q1 		$3.66M Buy
7,479
+598
+9% +$300K 0.13% 164
2020
Q4 		$3.44M Hold
6,881
– – 0.15% 135
2020
Q3 		$2.71M Sell
6,881
-30
-0.4% -$11.1K 0.11% 202
2020
Q2 		$2.28M Hold
6,911
– – 0.13% 163
2020
Q1 		$1.67M Sell
6,911
-107
-2% -$27.9K 0.12% 159
2019
Q4 		$1.83M Sell
7,018
-348
-5% -$91.7K 0.1% 179
2019
Q3 		$2M Sell
7,366
-900
-11% -$250K 0.12% 157
2019
Q2 		$2.28M Buy
8,266
+6,418
+347% +$1.58M 0.13% 152
2019
Q1 		$8.27K Sell
1,848
-6,418
-78% -$1.32M 0.03% 452
2018
Q4 		$1.54M Hold
8,266
– – 0.1% 168
2018
Q3 		$2.06M Hold
8,266
– – 0.12% 150
2018
Q2 		$1.8M Buy
8,266
+1,356
+20% +$279K 0.11% 168
2018
Q1 		$1.32M Hold
6,910
– – 0.09% 194
2017
Q4 		$1.08M Hold
6,910
– – 0.07% 224
2017
Q3 		$1.07M Hold
6,910
– – 0.07% 222
2017
Q2 		$1.11M Buy
+6,910
New +$1.12M 0.08% 216
2017
Q1 		– Sell
-5,112
Closed -$599K – 881
2016
Q4 		$599K Buy
+5,112
New +$583K 0.05% 319
2016
Q3 		– Sell
-9,136
Closed -$848K – 811
2016
Q2 		$848K Hold
9,136
– – 0.07% 225
2016
Q1 		$716K Hold
9,136
– – 0.06% 265
2015
Q4 		$666K Hold
9,136
– – 0.06% 261
2015
Q3 		$678K Hold
9,136
– – 0.07% 251
2015
Q2 		$586K Hold
9,136
– – 0.06% 320
2015
Q1 		$706K Sell
9,136
-694
-7% -$54K 0.08% 265
2014
Q4 		$729K Sell
9,830
-1,672
-15% -$117K 0.08% 242
2014
Q3 		$678K Hold
11,502
– – 0.09% 231
2014
Q2 		$768K Hold
11,502
– – 0.11% 200
2014
Q1 		$698K Hold
11,502
– – 0.1% 208
2013
Q4 		$612K Sell
11,502
-620
-5% -$32.6K 0.09% 239
2013
Q3 		$604K Sell
12,122
-284
-2% -$13.7K 0.1% 228
2013
Q2 		$557K Buy
+12,406
New +$542K 0.1% 218

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Shelton Capital Management's IDXX Position: Q2 2026 in Review

Shelton Capital Management reduced its Idexx Laboratories (IDXX) stake by 4.6% in Q2 2026, selling an estimated $243K and leaving 8,889 shares worth $4.68M. The position accounts for 0.09% of the portfolio, ranked #159.

Shelton Capital Management first reported a position in IDXX in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.45M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Shelton Capital Management held 8,889 shares of Idexx Laboratories worth $4.68M as of Q2 2026.
  • Shelton Capital Management sold 433 Idexx Laboratories shares in Q2 2026, an estimated $243K.
  • Idexx Laboratories made up 0.09% of Shelton Capital Management's portfolio in Q2 2026, its #159 holding.
  • Shelton Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 51 quarters since.
  • Shelton Capital Management's Idexx Laboratories position peaked at $6.45M in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Shelton Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.